[Plasma elimination of intravenously tolerated human immunoglobulins in patients suffering from humoral immune deficiencies. Studies on the protective action and time of protection following passive immunization].
D000361:Agammaglobulinemia / Q000188:drug therapy*; D000906:Antibodies; D006207:Half-Life; D006384:Hemagglutination; D006801:Humans; D007114:Immunization; D005779:Immunodiffusion; D007122:Immunoelectrophoresis; D007070:Immunoglobulin A / Q000378:metabolism; D007074:Immunoglobulin G / Q000378:metabolism; D007075:Immunoglobulin M / Q000378:metabolism; D007136:Immunoglobulins / Q000032:analysis / Q000378:metabolism / Q000627:therapeutic use*; D007275:Injections, Intravenous; D008297:Male; D008970:Molecular Weight; D013745:Tetanus Toxoid
D000906:Antibodies; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007136:Immunoglobulins; D013745:Tetanus Toxoid
Plasma-Elimination intravenös verträglicher menschlicher Immunglobuline bei Patienten mit humoralen Immundefekten. Untersuchungen zur Schutzwirkung und Schutzdauer nach passiver Immunisierung.